Literature DB >> 28721681

Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario.

Muhammad Umar Ali1, Muhammad Saif Ur Rahman2, Jiang Cao1, Ping Xi Yuan3.   

Abstract

Retinitis pigmentosa is a group of genetically transmitted disorders affecting 1 in 3000-8000 individual people worldwide ultimately affecting the quality of life. Retinitis pigmentosa is characterized as a heterogeneous genetic disorder which leads by progressive devolution of the retina leading to a progressive visual loss. It can occur in syndromic (with Usher syndrome and Bardet-Biedl syndrome) as well as non-syndromic nature. The mode of inheritance can be X-linked, autosomal dominant or autosomal recessive manner. To date 58 genes have been reported to associate with retinitis pigmentosa most of them are either expressed in photoreceptors or the retinal pigment epithelium. This review focuses on the disease mechanisms and genetics of retinitis pigmentosa. As retinitis pigmentosa is tremendously heterogeneous disorder expressing a multiplicity of mutations; different variations in the same gene might induce different disorders. In recent years, latest technologies including whole-exome sequencing contributing effectively to uncover the hidden genesis of retinitis pigmentosa by reporting new genetic mutations. In future, these advancements will help in better understanding the genotype-phenotype correlations of disease and likely to develop new therapies.

Entities:  

Keywords:  Autosomal dominant; Autosomal recessive; Retinitis pigments; Whole-exome sequencing; X-linked

Year:  2017        PMID: 28721681      PMCID: PMC5515732          DOI: 10.1007/s13205-017-0878-3

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  223 in total

1.  Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy.

Authors:  Naomi Chadderton; Sophia Millington-Ward; Arpad Palfi; Mary O'Reilly; Gearóid Tuohy; Marian M Humphries; Tiansen Li; Peter Humphries; Paul F Kenna; G Jane Farrar
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

2.  A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.

Authors:  Inga Ebermann; Hendrik P N Scholl; Peter Charbel Issa; Elvir Becirovic; Jürgen Lamprecht; Bernhard Jurklies; José M Millán; Elena Aller; Diana Mitter; Hanno Bolz
Journal:  Hum Genet       Date:  2006-12-15       Impact factor: 4.132

3.  Retinal disease expression in Bardet-Biedl syndrome-1 (BBS1) is a spectrum from maculopathy to retina-wide degeneration.

Authors:  Amir A Azari; Tomas S Aleman; Artur V Cideciyan; Sharon B Schwartz; Elizabeth A M Windsor; Alexander Sumaroka; Andy Y Cheung; Janet D Steinberg; Alejandro J Roman; Edwin M Stone; Val C Sheffield; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

Review 4.  Programmed cell death in retinal degeneration: targeting apoptosis in photoreceptors as potential therapy for retinal degeneration.

Authors:  Valeria Marigo
Journal:  Cell Cycle       Date:  2007-03-17       Impact factor: 4.534

5.  Comprehensive survey of mutations in RP2 and RPGR in patients affected with distinct retinal dystrophies: genotype-phenotype correlations and impact on genetic counseling.

Authors:  Valérie Pelletier; Marguerite Jambou; Nathalie Delphin; Elena Zinovieva; Morgane Stum; Nadine Gigarel; Hélène Dollfus; Christian Hamel; Annick Toutain; Jean-Louis Dufier; Olivier Roche; Arnold Munnich; Jean-Paul Bonnefont; Josseline Kaplan; Jean-Michel Rozet
Journal:  Hum Mutat       Date:  2007-01       Impact factor: 4.878

6.  Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older.

Authors:  S Grover; G A Fishman; R J Anderson; M S Tozatti; J R Heckenlively; R G Weleber; A O Edwards; J Brown
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

7.  Autosomal dominant macular degeneration associated with 208delG mutation in the FSCN2 gene.

Authors:  Yuko Wada; Toshiaki Abe; Toshitaka Itabashi; Hajime Sato; Miyuki Kawamura; Makoto Tamai
Journal:  Arch Ophthalmol       Date:  2003-11

8.  IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA.

Authors:  Sarah E Mortimer; Dong Xu; Dharia McGrew; Nobuko Hamaguchi; Hoong Chuin Lim; Sara J Bowne; Stephen P Daiger; Lizbeth Hedstrom
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

9.  Central areolar choroidal dystrophy.

Authors:  Camiel J F Boon; B Jeroen Klevering; Frans P M Cremers; Marijke N Zonneveld-Vrieling; Thomas Theelen; Anneke I Den Hollander; Carel B Hoyng
Journal:  Ophthalmology       Date:  2009-02-25       Impact factor: 12.079

10.  Role for the target enzyme in deactivation of photoreceptor G protein in vivo.

Authors:  S H Tsang; M E Burns; P D Calvert; P Gouras; D A Baylor; S P Goff; V Y Arshavsky
Journal:  Science       Date:  1998-10-02       Impact factor: 47.728

View more
  23 in total

1.  The clinical application of preimplantation genetic diagnosis for X-linked retinitis pigmentosa.

Authors:  Xinghua Huang; Yun Liu; Xiurong Yu; Qiuxiang Huang; Chunli Lin; Jian Zeng; Fenghua Lan; Zhihong Wang
Journal:  J Assist Reprod Genet       Date:  2019-03-19       Impact factor: 3.412

2.  Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.

Authors:  Umut Arslan; Emin Özmert; Sibel Demirel; Firdevs Örnek; Figen Şermet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-15       Impact factor: 3.117

3.  Novel compound heterozygous missense variants (c.G955A and c.A1822C) of CACNA2D4 likely causing autosomal recessive retinitis pigmentosa in a Chinese patient.

Authors:  Jingliang Cheng; Qi Zhou; Jiewen Fu; Chunli Wei; Lianmei Zhang; Md Shamsuddin Sultan Khan; Hongbin Lv; Songyot Anuchapreeda; Junjiang Fu
Journal:  3 Biotech       Date:  2021-04-10       Impact factor: 2.406

4.  Target 5000: Target Capture Sequencing for Inherited Retinal Degenerations.

Authors:  Adrian Dockery; Kirk Stephenson; David Keegan; Niamh Wynne; Giuliana Silvestri; Peter Humphries; Paul F Kenna; Matthew Carrigan; G Jane Farrar
Journal:  Genes (Basel)       Date:  2017-11-03       Impact factor: 4.096

5.  A novel splicing mutation in the PRPH2 gene causes autosomal dominant retinitis pigmentosa in a Chinese pedigree.

Authors:  Jingliang Cheng; Jiewen Fu; Qi Zhou; Xiaohong Xiang; Chunli Wei; Lisha Yang; Shangyi Fu; Md Asaduzzaman Khan; Hongbin Lv; Junjiang Fu
Journal:  J Cell Mol Med       Date:  2019-03-20       Impact factor: 5.310

Review 6.  Dyslipidemia in retinal metabolic disorders.

Authors:  Zhongjie Fu; Chuck T Chen; Gael Cagnone; Emilie Heckel; Ye Sun; Bertan Cakir; Yohei Tomita; Shuo Huang; Qian Li; William Britton; Steve S Cho; Timothy S Kern; Ann Hellström; Jean-Sébastien Joyal; Lois Eh Smith
Journal:  EMBO Mol Med       Date:  2019-09-05       Impact factor: 14.260

7.  An Update on Phosphodiesterase Mutations Underlying Genetic Etiology of Hearing Loss and Retinitis Pigmentosa.

Authors:  Rahul Mittal; Nicole Bencie; James M Parrish; George Liu; Jeenu Mittal; Denise Yan; Xue Zhong Liu
Journal:  Front Genet       Date:  2018-02-08       Impact factor: 4.599

8.  Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.

Authors:  Emin Özmert; Umut Arslan
Journal:  Stem Cell Res Ther       Date:  2020-08-12       Impact factor: 6.832

9.  A novel, homozygous nonsense variant of the CDHR1 gene in a Chinese family causes autosomal recessive retinal dystrophy by NGS-based genetic diagnosis.

Authors:  Jiewen Fu; Lu Ma; Jingliang Cheng; Lisha Yang; Chunli Wei; Shangyi Fu; Hongbin Lv; Rui Chen; Junjiang Fu
Journal:  J Cell Mol Med       Date:  2018-08-30       Impact factor: 5.310

10.  Lutein and Zeaxanthin Isomers Reduce Photoreceptor Degeneration in the Pde6b rd10 Mouse Model of Retinitis Pigmentosa.

Authors:  Minzhong Yu; Weiming Yan; Craig Beight
Journal:  Biomed Res Int       Date:  2018-12-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.